The first product liability trial over claims that Takeda Pharmaceutical’s diabetes drug Actos caused bladder cancer was tossed out of court more than two years ago, but a California appeal court recently ruled to reinstate a $6.5 million jury award against the Japanese drug company. On July 16, 2015, the appeals court held...
The first product liability trial over claims that Takeda Pharmaceutical’s diabetes drug Actos caused bladder cancer was tossed out of court more than two years ago.
